Conversely, SHIP2 loss or overexpression does not predispose mice to cancer development, suggesting that whilst the 5-phosphatase demonstrates pro-tumourigenic functions in breast cancer cell lines, it is not a bona fide oncogene. This evidence concerns the gene INPPL1 and breast carcinoma.